APRIL PAGE: Open Payments
NPI 1821720004 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,262 in 63 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $341 · 2025 $1,262
Food & beverage: $1,262
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $214 |
| Merck Sharp & Dohme LLC | 9 | $181 |
| Novo Nordisk Inc | 8 | $153 |
| Lilly USA, LLC | 7 | $116 |
| PFIZER INC. | 5 | $98 |
| Kowa Pharmaceuticals America, Inc. | 4 | $63 |
| ABBVIE INC. | 3 | $63 |
| Grifols USA, LLC | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $47 |
Products named: Kerendia, VERQUVO, MOUNJARO, Ozempic, ZORYVE, VRAYLAR, Prolastin-C Liquid, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
